Literature DB >> 24900861

Fused Thiazin-3-ones as KCa3.1 Inhibitors.

Benjamin Blass1.   

Abstract

Entities:  

Year:  2014        PMID： 24900861      PMCID： PMC4027580          DOI： 10.1021/ml500090s

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  2 in total

1.  Therapeutic potential of KCa3.1 blockers: recent advances and promising trends.

Authors:  Heike Wulff; Neil A Castle
Journal:  Expert Rev Clin Pharmacol       Date:  2010-05       Impact factor: 5.045

Review 2.  KCa3.1: target and marker for cancer, autoimmune disorder and vascular inflammation?

Authors:  Chuan-Chu Chou; Charles A Lunn; Nicholas J Murgolo
Journal:  Expert Rev Mol Diagn       Date:  2008-03       Impact factor: 5.225
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.